Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Handley

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
International Archives of Allergy and Applied Immunology|January 1, 1989
Effects of combined receptor antagonists of leukotriene D4 (LTD4) and platelet-activating factor (PAF) on rhesus airway responses to LTD4, PAF and antigenR Patterson, K E Harris, P R Bernstein, et al.
Pulmonary Pharmacology & Therapeutics|January 1, 1997
Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophilsA R Leff, A Herrnreiter, R M Naclerio, et al.
Immunopharmacology|August 1, 1986
Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonistD A Handley, R G Van Valen, M K Melden, et al.
Arteriosclerosis (Dallas, Tex.)|September 1, 1981
Effects of oscillatory mechanical disturbance on macromolecular uptake by arterial wallS Chien, M M Lee, L S Laufer, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1989
Terbinafine inhibits the mitogenic response to platelet-derived growth factor in vitro and neointimal proliferation in vivoG M Nemecek, I H St Denny, R G Van Valen, et al.
Arzneimittel-Forschung|December 1, 1994
Antitumor activity of a piperidine phospholipidW J Houlihan, M L Lee, P G Munder, et al.
Lipids|November 1, 1987
Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3W J Houlihan, M L Lee, P G Munder, et al.
Immunopharmacology|April 1, 1987
Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dogD A Handley, R G Van Valen, J C Tomesch, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1989
Chemistry and pharmacology of PAF antagonists. Evaluation of changes at potential metabolism sites on activity and duration of activityD A Handley, W J Houlihan, J C Tomesch, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
International Archives of Allergy and Applied Immunology|January 1, 1989
Effects of combined receptor antagonists of leukotriene D4 (LTD4) and platelet-activating factor (PAF) on rhesus airway responses to LTD4, PAF and antigenR Patterson, K E Harris, P R Bernstein, et al.
Pulmonary Pharmacology & Therapeutics|January 1, 1997
Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophilsA R Leff, A Herrnreiter, R M Naclerio, et al.
Immunopharmacology|August 1, 1986
Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonistD A Handley, R G Van Valen, M K Melden, et al.
Arteriosclerosis (Dallas, Tex.)|September 1, 1981
Effects of oscillatory mechanical disturbance on macromolecular uptake by arterial wallS Chien, M M Lee, L S Laufer, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1989
Terbinafine inhibits the mitogenic response to platelet-derived growth factor in vitro and neointimal proliferation in vivoG M Nemecek, I H St Denny, R G Van Valen, et al.
Arzneimittel-Forschung|December 1, 1994
Antitumor activity of a piperidine phospholipidW J Houlihan, M L Lee, P G Munder, et al.
Lipids|November 1, 1987
Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3W J Houlihan, M L Lee, P G Munder, et al.
Immunopharmacology|April 1, 1987
Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dogD A Handley, R G Van Valen, J C Tomesch, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1989
Chemistry and pharmacology of PAF antagonists. Evaluation of changes at potential metabolism sites on activity and duration of activityD A Handley, W J Houlihan, J C Tomesch, et al.
Pageof 7